Breaking through the Translation Barrier: Clinical Applications of Robotic Tech
Biomedical Engineering is aiming to develop novel medical technologies improving diagnosis and treatment of patients. The key issue is translation of the results into a viable and regulatory approved medical device. Not only that: reimbursement and successful clinal trials are further challenges. NICE recommendation in UK, MDR in Europe and FDA in USA and other countries are significant hurdles. Its estimated that 13-15 years are required to get a device to market. Patent protection last only 20 years.
During this year’s Clinical Forum we will have the opportunity to engage clinical and engineering experts in a lively discussion about the challenges and opportunities of translating medical technologies by exploring questions such as:
- How could biomedical engineering and clinical sciences work together to enable effective translation?
- How could a quality management system support translation?
- How do we tackle patient interest and acceptance?
- Who should pay for novel technologies?
- How to deal with regulatory approval, clinical trials and reimbursement?
- Stan Anderson, Neurosurgeon, John’s Hopkins University, USA
- Kevin Cleary, BME, Childrens National Medical Centre, Washington DC
- Gernot Kronreif, BME, ACMIT GmbH, Austria
- Arianna Menciassi, BME, Sant’Anna School of Advanced Studies, Italy
- Mark Slack, Chief Medical Officer and Consultant Gynaecologist, CMR Surgical, UK
Andreas Melzer, MD DDS, ICCAS University Leipzig and IMSaT University Dundee, UK
Date: Tuesday 27th June 2023
Time: 14:45 – 15:45